AzTrials
AzTrials

WoundsNCT02458859

Trial of PICO Versus Standard Care in Chronic and Sub-acute Wounds

A study testing PICO (single use portable negative pressure wound therapy) in people with Wounds, run by Smith & Nephew, Inc. at 20 sites in 2 countries.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Randomised Controlled Trial of PICO (a portable Negative Pressure Wound Therapy) versus standard care in patients with chronic and sub-acute wounds. Sample size 100 patients to investigate Time to healing, health economic and patient reported outcomes. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Wounds
What is being tested?
PICO (single use portable negative pressure wound therapy)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
20 sitesin 2 countries
Study dates
Mar 2012to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients >18 years old
  • Males and females. If female, they must not be pregnant or lactating. If female and of reproductive age, a pregnancy test will be provided.
  • The patient or their legal representative (if the patient is incapable of giving legal consent), is able to understand the trial and is willing to consent to the trial.
  • Patients with sub-acute or chronic wounds (diabetic foot ulcer, pressure ulcer, venous leg ulcer, or other chronic) suitable for treatment with a PICO dressing.
  • Wound duration ≤52 weeks - Amended to remove criteria.
  • Wound area range ≥5 cm2 at start of screening period
  • Wound maximum linear dimension ≤ 15cm
  • Able to use English for the interview

Who cannot join

  • Patients with known allergies to product components (silicone adhesives and polyurethane films (direct contact with wound), acrylic adhesives (direct contact with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within the dressing).
  • Wounds which have an infection which is not being treated with systemic antibiotics.
  • Wounds which are actively bleeding.
  • Exposure of blood vessels, organs, bone or tendon at the base of the reference wound
  • Exclude undermining or tunnelling present or suspected in the wound
  • Use of negative pressure device on wound in the last 30 days. Amended to remove criteria
Show all 12Show fewer
  • Malignant wounds/malignancy in the wound
  • Systemic infection not being treated with systemic antibiotics
  • Simultaneous treatment with other experimental wound care procedures, biologics or devices
  • Patients with a known history of poor compliance with medical treatment.
  • Patients who have participated in this trial previously and who closed or were withdrawn.
  • Patients who are unable to understand the aims and objectives of the trial.

Trial locations and contacts

20 sites in 2 countries.

20 sites in 2 countries

United Kingdom19 sites
  • Bradford District Care Trust

    Bradford

  • Papworth Surgery

    Cambridge

  • Cossington House Surgery

    Canterbury

  • Richmond House Surgery

    Crook of Devon

  • Barton Surgery

    Dawlish

  • Derby Hospit6al NHS Foundation Trust

    Derby

  • South Axholme Practice

    Doncaster

  • Sea Road Surgery

    Garway

  • Dr Moss & Partners

    Harrogate

  • The Honiton Group Practise

    Honiton

  • Leodis Care Limited

    Leeds, LS17 7PE

  • Barlow Medical centre

    Manchester

  • Wellfield Medical Centrre

    Manchester

  • Southbourne Surgery

    Milton of Campsie

  • Kiltearn Medical Centre

    Nantwich

  • Northumbria Healthcare NHS Trust

    Newcastle

  • South Tyneside NHS Foundation Trust

    Newcastle

  • Dr Jones & Partners

    Sedgefield

  • Brunel Medical practise

    Torquay

Other trials in United Kingdom

Canada1 site
  • Nursing Practise Solutions

    Altario

Other trials in Canada

About this study

Official title: A 100 Patient, Prospective, Randomised, Clinical Evaluation Comparing Clinical and Health Economic Outcomes Between Patients With Chronic or Sub-acute Wounds Treated With Either PICO or Standard Care Dressings and a Qualitative Study to Explore the Experiences of Patients Receiving PICO With Particular Emphasis on Concordance

Randomised Controlled Trial of PICO (a portable Negative Pressure Wound Therapy) versus standard care in patients with chronic and sub-acute wounds. Sample size 100 patients to investigate Time to healing, health economic and patient reported outcomes.

Read the detailed description

The current study is being conducted to assess the clinical and cost effectiveness of managing patients with a chronic or sub-acute wound in a community setting with PICO and to explore the patient experience and issues of concordance that affect patients treated with PICO. The study will provide information on the level of clinical benefit that PICO can deliver in the population studied in order to justify a sample size for a definitive evaluation of PICO and the study will further assess wound types that may benefit from treatment with PICO.

Conditions
Wounds
Being tested
PICO (single use portable negative pressure wound therapy)
Keywords
Chronic, Subacute
Medical subject headings
Wounds and Injuries, Bronchiolitis Obliterans Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PICO (single use portable negative pressure wound therapy)Device

    Single use portable negative pressure wound therapy

Study groups in NCT02458859
Study groupRoleWhat they receive
PICOActive comparatorPICO Negative Pressure Wound Therapy (NPWT) system
Receives: Device: PICO (single use portable negative pressure wound therapy)
Standard careNo interventionStandard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to closure

    Time to complete wound closure

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2015 (estimated)
  2. Study startMar 2012
  3. Primary completionJun 2015
  4. Study completionJun 2015

Why it stopped: Poor recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02458859
Sponsor's protocol ID
CE/044/PIC
Status last verified
Feb 2018
First submitted
18 Aug 2011
Last updated
13 Feb 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing PICO (single use portable negative pressure wound therapy) in people with Wounds, run by Smith & Nephew, Inc. at 20 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 13 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 20 sites in United Kingdom, Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Poor recruitment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to closure (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in